Avoid other sedatives during DSIP use to clearly evaluate its effects on sleep
1 Introduction Multiple sclerosis (MS), an immunoinflammatory disease, is caused by the chronic demyelination of nerve axons and, thus, disrupts the function of the central nervous system (CNS), eventually leading to severe disability, such as autonomic dysfunction, paralysis, disability of motor control, and cognitive impairment of the brain (www.atlasofms.org), which is compiled and updated by the Multiple Sclerosis International Federation (MSIF), it is estimated that 2.8 million people are affected by MS worldwide
Light Protection Lyophilised IGF-1 LR3 should be stored in light-protected containers: Use original amber or opaque vials provided by the supplier Store vials in a dark cupboard or drawer within the refrigerator Do not expose vials to direct sunlight or bright artificial light If transferring to secondary containers, use opaque, UV-protective vials Light exposure can accelerate peptide degradation through photochemical reactions
Underdosing by 50% (a common error with standard 1mL syringes) means you're running a 0.25mg protocol when you intended 0.5mg
A sample size calculation using a two-tailed t-test to achieve a power of 80% and alpha of 5%, with a SD = 0.8 and expected difference of 1.2 between groups, indicates that 9 women per study group would be required for the present study